Jim Simons
IGC icon

Jim Simons’s IGC Pharma IGC Stock Holding History

Jim Simons’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$127K Sell
483,975
-435,666
-47% -$121K ﹤0.01% 2991
2025
Q4 		$259K Sell
919,641
-299,324
-25% -$107K ﹤0.01% 2814
2025
Q3 		$508K Buy
1,218,965
+1,163,940
+2,115% +$443K ﹤0.01% 2784
2025
Q2 		$16.8K Buy
+55,025
New +$16.5K ﹤0.01% 3482
2024
Q2 		– Sell
-141,303
Closed -$57K – 3715
2024
Q1 		$57K Buy
+141,303
New +$43.9K ﹤0.01% 3460
2023
Q4 		– Sell
-86,902
Closed -$31K – 3891
2023
Q3 		$31K Sell
86,902
-75,807
-47% -$27.1K ﹤0.01% 3464
2023
Q2 		$51K Buy
162,709
+52,409
+48% +$17K ﹤0.01% 3613
2023
Q1 		$37K Sell
110,300
-111,711
-50% -$41.9K ﹤0.01% 3720
2022
Q4 		$71K Sell
222,011
-98,889
-31% -$40.3K ﹤0.01% 3716
2022
Q3 		$138K Buy
320,900
+103,151
+47% +$55K ﹤0.01% 3498
2022
Q2 		$115K Buy
+217,749
New +$137K ﹤0.01% 3812
2021
Q4 		– Sell
-436,800
Closed -$646K – 4047
2021
Q3 		$646K Buy
436,800
+138,685
+47% +$224K ﹤0.01% 2776
2021
Q2 		$489K Buy
+298,115
New +$455K ﹤0.01% 2974
2020
Q4 		– Sell
-110,622
Closed -$115K – 3528
2020
Q3 		$115K Buy
+110,622
New +$112K ﹤0.01% 3199

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Jim Simons's IGC Position: Q1 2026 in Review

Jim Simons reduced its IGC Pharma (IGC) stake by 47% in Q1 2026, selling an estimated $121K and leaving 483,975 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #2991.

Jim Simons first reported a position in IGC in Q3 2020 and has held it in 14 quarters since. The position peaked at $646K in Q3 2021. 35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

  • Jim Simons held 483,975 shares of IGC Pharma worth $127K as of Q1 2026.
  • Jim Simons sold 435,666 IGC Pharma shares in Q1 2026, an estimated $121K.
  • IGC Pharma made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2991 holding.
  • Jim Simons first reported a position in IGC Pharma in Q3 2020 and has held it in 14 quarters since.
  • Jim Simons's IGC Pharma position peaked at $646K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.